Main navigation

• Home
• Our medicines
• Diseases and conditions
• Community support
• Help affording your medicines
• Research & development
• Healthcare professionals
• Careers
• About AstraZeneca US
  • Investors
  • Our company
  • AZ on the issues
  • Responsible business
  • Newsroom
    • Media resources
    • All news
    • Corporate news
    • Financial news
    • Product news
    • Research news
  • US web sites
  • Contact us

You are here

• Home
• About AstraZeneca US
• Newsroom

• News

The following shows headlines of all news articles published within 12-months, starting from most recent.

• Pages
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9

• • Feb 10, 2009
  • AstraZeneca helped more than 440,000 patients save $612 million on medicines in 2008  
• • Feb 9, 2009
  • AstraZeneca licenses novel antidepressant compounds discovered by Mayo Clinic and Virginia Tech collaboration  
• • Feb 4, 2009
  • AstraZeneca commends passage, signing of Children’s Health Bill  
• • Jan 29, 2009
  • AstraZeneca PLC fourth quarter and full year results 2008  
• • Jan 8, 2009
  • AstraZeneca applauds nationwide call to keep healthcare reform in the spotlight  
• • Dec 19, 2008
  • AstraZeneca submits sNDA for NEXIUM® for the short-term treatment of GERD in infants 0 to 1 year old  
• • Dec 11, 2008
  • AstraZeneca responds to FDA Joint Advisory Committees’ recommendation on SYMBICORT®  
• • Dec 10, 2008
  • AstraZeneca commends PhRMA’s expanded direct-to-consumer advertising guidelines  
• • Dec 8, 2008
  • AstraZeneca and Targacept announce top-line results from Phase IIb study of AZD3480 in cognitive dysfunction in schizophrenia  
• • Dec 3, 2008
  • AstraZeneca appoints Graham Baker Vice President and Chief Financial Officer for North America  

• Pages
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed